Results 201 to 210 of about 236,396 (261)

Metastatic Cutaneous Adnexal Carcinoma of the Head and Neck With Durable Response to an Aromatase Inhibitor Combined With a Cyclin‐Dependent Kinase 4/6 Inhibitor

Head &Neck, EarlyView.
ABSTRACT Background Cutaneous adnexal carcinomas are a very rare group of cancers arising from appendageal structures of the skin. More than half occur in the head and neck region. No standard treatments exist for metastatic disease. Methods A 48‐year‐old postmenopausal female presented with an enlarging scalp lesion.
Nilesh Kapoor, Manasa Narasimman, Travis Vandergriff, Amy L. Jones   +3 more
wiley   +1 more source

Defining prognostic subgroups and treatment outcomes in estrogen receptor low-positive de novo metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Klugman MF, Aboumrad M, Chen R, Marshall CH, Canzoniero JV, Wolff AC, Visvanathan K.   +6 more
europepmc   +1 more source

HSD17B7 Counters Bone Loss in Estrogen Deficiency via Estrogen Receptor Stabilization and Mediates the Effect of Raloxifene. [PDF]

MedComm (2020)
Zhang J, Song Y, Koo JH, Chen S, Jang KY, Yoon SJ, Kim JR, Moon YJ.   +7 more
europepmc   +1 more source

Integrin αvβ3 as a Non-Genomic Estrogen Receptor in Breast Cancer for Signaling Pathways and Crosstalk. [PDF]

Cells
Wang K, Li ZL, Huang LY, Yao CJ, Crawford DR, Wang CY, Mo JK, Shih YJ, Lin HY, Whang-Peng J.   +9 more
europepmc   +1 more source

The DIKW of Transcriptomics in Ecotoxicology: Extracting Information, Knowledge, and Wisdom From Big Data

Environmental Toxicology and Chemistry, EarlyView.
Jessica A. Head, Jessica D. Ewald, Niladri Basu   +2 more
wiley   +1 more source

Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer. [PDF]

Int J Mol Sci
Ormiston K, Shinde N, Sarathy G, Zhang A, Bauer M, Shukla RK, Alsammerai S, Gupta A, Bennouna D, Wesolowski J, Zhang X, Kopec RE, Shankar E, Stanford KI, Ganju RK, Majumder S, Ramaswamy B, Stover DG.   +17 more
europepmc   +1 more source

Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancer. [PDF]

EMBO Mol Med
Manivannan M, Jehanno C, Kloc M, Gomez Miragaya J, Diepenbruck M, Volkmann K, Coissieux MM, Palafox M, Rouchon A, Kramer N, Schmidt A, Blum Y, Hamelin B, Schuster H, Heidinger M, Muenst S, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M.   +19 more
europepmc   +1 more source

Impact of estrogen receptor expression levels on chemo-responsiveness and prognosis of breast cancer patients treated with neoadjuvant chemotherapy. [PDF]

NPJ Breast Cancer
Bai K, Sung HJ, Chung YR, Shin HC, Kim EK, Suh KJ, Kim SH, Kim JH, Kwon HJ, Park SY.   +9 more
europepmc   +1 more source

Longitudinal Analysis of Estrogen Receptor Gene Methylation, Estradiol, and Depressive Symptoms During the Perinatal Period. [PDF]

Mol Neurobiol
Zorzini G, Johann A, Dukic J, Gardini E, Ehlert U.   +4 more
europepmc   +1 more source